Published 5 hours ago • loading... • Updated 2 hours ago
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
Summary by Post Register
4 Articles
4 Articles
ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026
Cambridge, Massachusetts, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced it will report financial results for the third quarter…
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center1Last Updated50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium







